One test, four diseases: could this be the end of missed diagnoses?
NCT ID NCT07170748
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests a new device called MagIA H3S that can screen for HIV, hepatitis B, hepatitis C, and syphilis using a single blood sample. Researchers will enroll about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab tests. If it works well, it could make widespread screening easier in areas with limited healthcare resources.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de Diagnostic et de Recherche sur le SIDA et les autres Maladies Infectieuses - CHU Treichville
RECRUITINGAbidjan, Côte d’Ivoire
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kenya Medical Research Institute (KEMRI)
RECRUITINGNairobi, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MagIA H3S diagnostic device
What this could lead to
If successful, this could provide a fast, affordable way to test for four major infections at once, improving early detection in remote areas.
What could go wrong
This is a performance evaluation, not a treatment trial. The device may not be as accurate as lab tests, and results may vary across populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.